[
  {
    "ts": null,
    "headline": "Quest Diagnostics (DGX): Evaluating Valuation as Analyst Optimism Builds Ahead of Upcoming Q3 Results",
    "summary": "Quest Diagnostics (DGX) is set to release its third-quarter results soon, drawing investor attention because of its recent track record of positive earnings surprises and upbeat sentiment from analysts ahead of the announcement. See our latest analysis for Quest Diagnostics. Quest Diagnostics has ridden a wave of positive sentiment, with its share price notching a 21.93% gain year-to-date and a remarkable 25.87% total return over the past 12 months. This momentum, fueled by consistent...",
    "url": "https://finnhub.io/api/news?id=3b35f84207a6fa2736d1e6bc0ab025b1f298b59f0abeff15607c44911275226f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760389502,
      "headline": "Quest Diagnostics (DGX): Evaluating Valuation as Analyst Optimism Builds Ahead of Upcoming Q3 Results",
      "id": 137074582,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics (DGX) is set to release its third-quarter results soon, drawing investor attention because of its recent track record of positive earnings surprises and upbeat sentiment from analysts ahead of the announcement. See our latest analysis for Quest Diagnostics. Quest Diagnostics has ridden a wave of positive sentiment, with its share price notching a 21.93% gain year-to-date and a remarkable 25.87% total return over the past 12 months. This momentum, fueled by consistent...",
      "url": "https://finnhub.io/api/news?id=3b35f84207a6fa2736d1e6bc0ab025b1f298b59f0abeff15607c44911275226f"
    }
  },
  {
    "ts": null,
    "headline": "Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks",
    "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 115 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
    "url": "https://finnhub.io/api/news?id=c5c920836b06ec9fe21d170f703e4b586a335090a76491efce2029edadcb3977",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760372999,
      "headline": "Walt Disney Upgraded, Southwest Airlines Downgraded: Updated Rankings on Top Blue-Chip Stocks",
      "id": 137165284,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 115 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up",
      "url": "https://finnhub.io/api/news?id=c5c920836b06ec9fe21d170f703e4b586a335090a76491efce2029edadcb3977"
    }
  },
  {
    "ts": null,
    "headline": "Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus",
    "summary": "MariMed, Xeris Biopharma and Lam Research shine as Zacks' proven stock strategies continue to beat the market despite turmoil.",
    "url": "https://finnhub.io/api/news?id=f1f5c4686ae20fa3783e4e21c26d2019407230d0a16edd57a26a982bfbed6521",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760356680,
      "headline": "Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus",
      "id": 137067117,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "MariMed, Xeris Biopharma and Lam Research shine as Zacks' proven stock strategies continue to beat the market despite turmoil.",
      "url": "https://finnhub.io/api/news?id=f1f5c4686ae20fa3783e4e21c26d2019407230d0a16edd57a26a982bfbed6521"
    }
  },
  {
    "ts": null,
    "headline": "What to Expect From Quest Diagnostics’ Next Quarterly Earnings Report",
    "summary": "Quest Diagnostics is gearing up to announce its third-quarter results in the upcoming week, and analysts expect a notable single-digit growth in earnings.",
    "url": "https://finnhub.io/api/news?id=b77a13f6528b1c235ab2f5e42b64cee7b514451254aef53ac84bf0c2ad9e3d0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760329338,
      "headline": "What to Expect From Quest Diagnostics’ Next Quarterly Earnings Report",
      "id": 137066562,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics is gearing up to announce its third-quarter results in the upcoming week, and analysts expect a notable single-digit growth in earnings.",
      "url": "https://finnhub.io/api/news?id=b77a13f6528b1c235ab2f5e42b64cee7b514451254aef53ac84bf0c2ad9e3d0e"
    }
  }
]